Document is current
Any future updates will be listed below
-
Authors
Pi, Yubo
Wang, Jingshi
Zhou, Hui
Ye, Xiujin
Sun, Xiuhua
Liu, Ligen
Pan, Xueyi
Wang, Zhao
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04077905 at ClinicalTrials.govDocuments that mention this clinical trial
Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study
https://doi.org/10.1007/s00432-022-04157-0
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 81871633)
Beijing Natural Science Foundation (No. 7181003)
Beijing Municipal Administration of Hospitals’ Ascent Plan (DFL20180101)
- License Information
-
More Information
Article History
Received: 3 May 2022
Accepted: 15 June 2022
First Online: 19 July 2022
Declarations
:
: The authors declare no competing interests.
: The authors declare that they have no competing interests.
: This study was approved by the Ethics Committee of Beijing Friendship Hospital.
: Informed consent was obtained from all the participants.
: We obtained consent to publish from all the participants.
